This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Don't Sell in May, Rather Buy These ETFs
by Sanghamitra Saha
The proverb "sell in May and go away" proved itself wrong in the past few years with the May-October period turning pretty profitable.
ETF Asset Report of Coronavirus-Inflicted April
by Sanghamitra Saha
These ETF areas have gained or lost assets in the month of April.
Healthcare ETFs to Gain on Progress in Coronavirus Vaccine
by Sweta Jaiswal, FRM
The healthcare space is heated up with players rushing to come up with a vaccine for COVID-19.
Healthcare ETFs Looks Strong Ahead of Q1 Earnings
by Sweta Killa
The healthcare sector has been on a tear driven by potential vaccines and treatments for COVID-19.
Healthcare ETFs to Gain on Progress in COVID-19 Antibody Tests
by Sweta Jaiswal, FRM
Along with molecular testing, antibody testing is gaining immense prominence as economies are struggling to reopen.
Healthcare ETFs in Focus Post UnitedHealth's Q1 Earnings
by Sweta Killa
UnitedHealth reported mixed first-quarter 2020 results wherein it breezed past the Zacks Consensus Estimate on earnings but lagged the same for revenues.
JNJ Beats, Cuts View on Coronavirus: Healthcare ETFs in Focus
by Sweta Killa
Investors should closely watch the movement of the stock and keep a close eye on ETFs having double-digit allocation to this diversified drug maker post its earnings release.
4 Good Quality Sector ETFs & Stocks to Buy Right Now
by Sanghamitra Saha
These sectors are extremely well-positioned to survive market shocks. Buy the related ETFs and stocks.
Healthcare Stocks & ETFs to Gain on Coronavirus Test Progress
by Sweta Jaiswal, FRM
It seems that testing for COVID-19 is the major key in controlling the outbreak and helps in making decisions like treatment protocols, resource allocation and drafting the right healthcare policies.
Biotech Stocks & ETFs to Gain on Progress in COVID-19 Vaccine Development
by Sweta Jaiswal, FRM
The rampant race to introduce a vaccine for the COVID-19 is creating near-term opportunities, making the biotech sector a lucrative space for investments.
Healthcare ETFs Gain on Rising Demand for COVID-19 Tests
by Sweta Jaiswal, FRM
A growing demand for COVID-19 tests has indulged major healthcare place in the race to develop competent testing kits.
ETF Strategies & Best Practices Amid Coronavirus Volatility
by Neena Mishra
Here are some ideas for navigating these turbulent times.
US Stimulus Should Support These 7 ETFs
by Sanghamitra Saha
While all corners of the market should see a spike from the U.S. stimulus, a few specific areas and the related ETFs should fare even better, courtesy of cheaper valuation and the stimulus tailwind.
Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?
by Zacks Equity Research
Sector ETF report for PSCH
Has Wall Street's March Madness Peaked? ETFs to Tap
by Sanghamitra Saha
Some Wall Street strategists believe that volatility in the markets has peaked and markets may turn around on Fed stimulus. Play these ETFs.
Tackle Market Gyrations With Buffett's Style of ETF Investing
by Sanghamitra Saha
Wall Street is in a bear market. Survive the slump with ETF strategies that are derived from the Warren Buffett???s style of investing.
Is the Virus-Induced Stock Selloff Overdone? ETFs to Buy Now
by Sanghamitra Saha
JPMorgan Chase believes that the stock selloff is overdone. One can buy beaten-down ETFs with strong Zacks ranks, benchmark-beating yields and beta less than one.
Beat Virus With 2 Sector ETFs & Stocks That Survived 2008 Crisis
by Sanghamitra Saha
These two sectors lost lesser than the broader market during the 2008 financial crisis and may help you to tide over the latest virus crisis.
Forget 'Black Monday': Bet on ETFs & Stocks Trading Cheap
by Sanghamitra Saha
Use the dip witnessed on Black Monday and buy these cheap ETFs and stocks for the long run.
5 Top-Ranked Sector ETFs to Buy at Bargain Price
by Sweta Killa
Given the strong widespread expectations of easing of global monetary policy, investors should take advantage of the beaten down prices.
Follow Warren Buffett With These ETF Strategies
by Sanghamitra Saha
These ETF strategies replicate Buffett's view about the today's investing world.
Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?
by Sweta Killa
Sector ETF report for PSCH
Should You 'Buy or Sell' on the Headlines? ETFs for Long Run
by Sanghamitra Saha
The coronavirus scare may have derailed market momentum, but one may choose to focus on long-term fundamentals and buy these ETFs.
Looking to Buy the Dip? Play These Top-Ranked ETFs
by Sanghamitra Saha
As the coronavirus fear escalated in the market, Wall Street took a hit on Friday. Play the dip with these top-ranked ETFs.
Wining & Losing ETF Areas on Coronavirus Outbreak
by Sanghamitra Saha
Coronavirus outbreak puts these ETF areas in winning and losing positions.